DSIP

Also known as: Delta Sleep-Inducing Peptide, DSIP

Cognitive Enhancement

Research Only

DSIP (Delta Sleep-Inducing Peptide) is an endogenous nonapeptide that was originally discovered for its ability to induce delta (slow-wave) sleep when infused into rabbits. It has since been found to have diverse neuromodulatory, stress-reducing, and hormone-regulatory effects beyond sleep induction.

Regulatory & Approval Status

Not FDA Approved

Delta Sleep-Inducing Peptide (DSIP) is a research-only compound with no FDA approval and no current clinical trial status for human therapeutic use.

Information compiled from FDA compounding guidance and public regulatory sources. For research and educational purposes only; not medical advice.

Unlock the complete research profile

Create your free CertifiedTide account to access full compound details, mechanisms, safety data, and research tools.